Company intelligence / Profile preview
Nalu Bio
- Ownership
- Private
- Employees
- ~15
- Development stage
- Other
Overview
Nalu Bio is a biotechnology company specializing in the development of high-purity, nature-identical synthetic cannabinoids. By utilizing a proprietary chemistry-based synthesis platform, the company bypasses the limitations of traditional hemp extraction, such as heavy metal contamination and THC presence. Nalu Bio focuses on creating consistent, scalable, and sustainable cannabinoid ingredients for the pharmaceutical, wellness, and consumer goods industries. Their pipeline includes therapeutic candidates targeting pain, inflammation, and neurological disorders. The company aims to set a new standard for safety and efficacy in the cannabinoid market through rigorous scientific validation.
- Therapeutic areas
- PsychiatryImmunologyNeurologyMetabolic Disorders
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
14 assets13 more assets in the full pipeline.
Beyond the preview
Go deeper on Nalu Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nalu Bio.